10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …
maintaining multiorgan health and homeostasis. Endothelial functions in health include …
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network …
Objective To evaluate sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-
like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …
like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …
Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association
R Pop-Busui, JL Januzzi, D Bruemmer… - Diabetes …, 2022 - Am Diabetes Assoc
Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
DR Junqueira, L Zorzela, S Golder, Y Loke, JJ Gagnier… - Bmj, 2023 - bmj.com
Randomised controlled trials remain the reference standard for healthcare research on
effects of interventions, and the need to report both benefits and harms is essential. The …
effects of interventions, and the need to report both benefits and harms is essential. The …
Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and …
TA Zelniker, SD Wiviott, I Raz, KA Im, EL Goodrich… - Circulation, 2019 - Am Heart Assoc
Background: Glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose
cotransporter-2 inhibitors (SGLT2i) have emerged as 2 new classes of antihyperglycemic …
cotransporter-2 inhibitors (SGLT2i) have emerged as 2 new classes of antihyperglycemic …
Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline
SD Navaneethan, S Zoungas, ML Caramori… - Annals of internal …, 2021 - acpjournals.org
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization
developed a clinical practice guideline in 2020 for the management of patients with diabetes …
developed a clinical practice guideline in 2020 for the management of patients with diabetes …
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the …
J Rosenstock, D Allison, AL Birkenfeld, TM Blicher… - Jama, 2019 - jamanetwork.com
Importance Phase 3 trials have not compared oral semaglutide, a glucagon-like peptide 1
receptor agonist, with other classes of glucose-lowering therapy. Objective To compare …
receptor agonist, with other classes of glucose-lowering therapy. Objective To compare …
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association - Diabetes care, 2019 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …